Singapore markets closed

Brightcove Inc. (BCOV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1850+0.0550 (+2.58%)
As of 11:37AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 94.96M
Enterprise value 93.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.46
Price/book (mrq)0.98
Enterprise value/revenue 0.46
Enterprise value/EBITDA 38.45

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-48.18%
S&P500 52-week change 326.14%
52-week high 34.5600
52-week low 31.5500
50-day moving average 31.8786
200-day moving average 32.5527

Share statistics

Avg vol (3-month) 3222.4k
Avg vol (10-day) 3239.12k
Shares outstanding 544.58M
Implied shares outstanding 644.58M
Float 828.71M
% held by insiders 15.68%
% held by institutions 176.03%
Shares short (15 May 2024) 41.67M
Short ratio (15 May 2024) 48.04
Short % of float (15 May 2024) 45.08%
Short % of shares outstanding (15 May 2024) 43.75%
Shares short (prior month 15 Apr 2024) 41.66M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -4.74%
Operating margin (ttm)-4.73%

Management effectiveness

Return on assets (ttm)-3.01%
Return on equity (ttm)-10.02%

Income statement

Revenue (ttm)202.6M
Revenue per share (ttm)4.66
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)N/A
EBITDA -3.12M
Net income avi to common (ttm)-9.6M
Diluted EPS (ttm)-0.2100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)22.87M
Total cash per share (mrq)0.51
Total debt (mrq)20.96M
Total debt/equity (mrq)21.55%
Current ratio (mrq)0.74
Book value per share (mrq)2.18

Cash flow statement

Operating cash flow (ttm)19.16M
Levered free cash flow (ttm)11.86M